
On-site oxygen systems now serve critical roles in:
| Aspect | Localised Oxygen Generation | Traditional Supply (Cylinders / Liquid) |
| Reliability | Continuous operation, independent of logistics or weather interruptions | Prone to delivery delays, especially in remote or island locations |
| Cost Efficiency | 30–70% lower OPEX once installed; no transport or rental fees | Ongoing delivery, rental, and fuel costs accumulate over time |
| Safety | Lower handling risks—no high-pressure cylinders or cryogenic storage | Cylinder shifting and refills introduce handling and storage hazards |
| Scalability | Modular design allows easy expansion as demand grows | Limited by delivery scheduling and supply contracts |
| Sustainability | No transport emissions or production waste | High carbon footprint from liquefaction and transport logistics |
As industrial operators move toward decarbonisation and supply-chain resilience, these benefits are compelling across both metropolitan and remote operations.
Key Advantages
These benefits are amplified across regions like Papua New Guinea, Fiji, Samoa, and rural Australia, where logistics and terrain make consistent supply a persistent challenge.

Access to safe and continuous medical oxygen is vital—but traditional supply models often fail to meet this need across the Pacific and rural Australasia. Remote hospitals and clinics depend on infrequent bulk deliveries or fly-in cylinders that are costly and prone to interruption.
On-site oxygen generation addresses these exact risks. PSA medical oxygen systems from EHL Group and AirSep produce a continuous stream of 93–95% oxygen, fully compliant with ISO 10083 and major hospital standards.
In regions like PNG, Solomon Islands, and rural Queensland, weather and infrastructure can delay logistics for weeks. Locally generated medical oxygen eliminates that single point of failure, offering true supply security. Hospitals gain control of production, avoid cylinder stockouts, and maintain consistent life-support capability—even in emergencies or disaster response scenarios.
EHL Group’s healthcare portfolio includes modular oxygen generation plants integrated with local reticulation systems, containerised designs for remote hospitals, and turnkey projects combining air compression, PSA generation, receivers, and distribution control.

In the mining sector—especially gold processing—oxygen is an essential reagent. High-purity oxygen enhances cyanidation kinetics, reduces cyanide consumption, and improves the overall recovery rate. However, conventional bulk oxygen supply is logistically expensive and operationally high-risk for remote mines in Western Australia, Papua New Guinea, and the Pacific.
With EHL Group’s engineered PSA and VPSA oxygen systems, miners achieve independent, locally generated oxygen production tailored to process flow rates and site conditions.
Technical Performance
EHL Group has designed and commissioned complete oxygen systems for gold, copper, and nickel operations, integrating plant control, receiver tanks, and ring-main pipelines. Their end-to-end capability—from concept to commissioning—ensures reliable performance under demanding environmental and operational conditions.

Municipal and industrial wastewater plants across New Zealand, Australia, and the Pacific Islands face growing demands for performance and energy efficiency. Maintaining high dissolved oxygen levels is key to supporting aerobic biological processes for BOD and COD reduction.
Localised oxygen generation provides a stable, controllable supply of oxygen without chemical oxidants or reliance on cylinder deliveries.
Technical Advantages
For coastal and island wastewater plants in Fiji, Tonga, and the Cook Islands, local generation eliminates the need for frequent compressed oxygen shipments—reducing costs and environmental impact. Similarly, Australian water utilities leverage oxygen systems to optimise lagoon or oxidation ditch performance with lower operating overheads.

EHL Group combines technical excellence with strong regional insight. Their multidisciplinary team delivers turnkey oxygen solutions that withstand the Pacific’s tough environmental conditions and logistical constraints. Each system is engineered for reliability, safety, and lifecycle value, backed by local support teams offering:
Their partnerships with AirSep and other key supply partners ensure OEM-backed reliability with proven global support.
From hospitals to gold mines to municipal treatment plants, on-site oxygen generation is redefining how vital industries across Australia, New Zealand, and the Pacific source oxygen. With EHL Group’s engineering expertise, organisations no longer have to accept delivery bottlenecks, safety risks, or escalating logistics costs.
EHL builds independence—oxygen on demand, where and when it’s needed.
While localised oxygen systems require initial capital investment, the lifetime cost savings and reliability outweigh traditional delivery models within two to three years. There is no exposure to market fluctuations in bulk oxygen pricing, shipping delays, or contract dependencies — critical for the Pacific Islands and remote Australian outposts where logistics are complex and weather-dependent.
Add to this the minimal maintenance and robust 20+ year operating life of AirSep VPSA systems, and the case becomes even stronger. The return is not just financial: it’s operational independence and environmental responsibility.
Across the Pacific and Australasia, the shift toward localised oxygen generation is well underway. With strong local support from EHL Group, industries can secure a dependable supply of oxygen tailored precisely to their needs—reducing costs, mitigating risks, and contributing to a more sustainable regional future.
Contact EHL Group at solutions@ehlsolutions.com and explore how their engineering team can customise a system for your industry.







